Prospective cohort study compares recurrence rates and quality of life in early-stage breast cancer patients, suggesting BCS may enhance quality of life.
Objectives: To compare the clinical outcomes, recurrence rates, post-operative complications, and quality of life between patients undergoing BCS and MRM for early-stage breast cancer. Study Design and Setting: This was a prospective cohort study (comparative) conducted at DHQ Teaching hospital Narowal Methodology: This one-year study (January 2023–January 2024) included 93 early-stage breast cancer patients, with 46 undergoing MRM and 47 BCS. Demographics, tumor traits, recurrence rates, complications, and quality-of-life outcomes were analyzed. Statistical tests, including chi-square were performed using SPSS version 20. Results: Complications occurred in 18.1% (17 out of 93) patients in which 7 (14.9%) were from the BCS group, and 10 (21.7%) were from the MRM group. Recurrence rate was 10.9% in MRM group and 4.3% for the BCS group (P<.05). Wound infection was more common in the MRM group (6.5%) compared to the BCS group (4.3%), though this difference was not statistically significant (p = 0.41). Tests of quality of life at the end of a year revealed that BCS patients have far better body image and mental health findings than MRM patients. Conclusion: Although BCS offers higher quality-of- life results, both BCS and MRM are appropriate surgical choices for early-stage breast cancer. These findings make BCS appear like a reasonable choice compared to MRM, More research is advised using larger samples
No takes yet. Share an insight, caveat, or question.
Mengal et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: